Robert Keenan presented long-term safety and tolerability of pozdeutinurad alone or in combination with allopurinol in gout patients with subcutaneous tophi—data from a Phase II open-label trial.

Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to ...

Ear-wax build up or blockages can be frustrating, and potentially cause further health issues. Many GP surgeries no longer offer removal, so what's the best way to deal with problem ear wax? If you're ...